COKU, Jorida, David M BOOTH, Jan ŠKODA, Madison C PEDROTTY, Jennifer VOGEL, Kangning LIU, Annette VU, Erica L CARPENTER, Jamie C YE, Michelle A CHEN, Peter DUNBAR, Elizabeth SCADDEN, Taekyung D YUN, Eiko NAKAMARU-OGISO, Estela AREA-GOMEZ, Yimei LI, Kelly C GOLDSMITH, C Patrick REYNOLDS, Gyorgy HAJNOCZKY and Michael D HOGARTY. Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance. EMBO Journal. Hoboken: Wiley, 2022, vol. 41, No 8, p. 1-20. ISSN 0261-4189. Available from: https://dx.doi.org/10.15252/embj.2021108272.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance
Authors COKU, Jorida, David M BOOTH, Jan ŠKODA (203 Czech Republic, belonging to the institution), Madison C PEDROTTY, Jennifer VOGEL, Kangning LIU, Annette VU, Erica L CARPENTER, Jamie C YE, Michelle A CHEN, Peter DUNBAR, Elizabeth SCADDEN, Taekyung D YUN, Eiko NAKAMARU-OGISO, Estela AREA-GOMEZ, Yimei LI, Kelly C GOLDSMITH, C Patrick REYNOLDS, Gyorgy HAJNOCZKY and Michael D HOGARTY (guarantor).
Edition EMBO Journal, Hoboken, Wiley, 2022, 0261-4189.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 11.400
RIV identification code RIV/00216224:14310/22:00125550
Organization unit Faculty of Science
Doi http://dx.doi.org/10.15252/embj.2021108272
UT WoS 000760798100001
Keywords in English ceramides; inter-organelle contacts; mitochondria-associated membranes; multidrug resistance; sphingolipids
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 3/6/2022 13:45.
Abstract
Most cancer deaths result from progression of therapy resistant disease, yet our understanding of this phenotype is limited. Cancer therapies generate stress signals that act upon mitochondria to initiate apoptosis. Mitochondria isolated from neuroblastoma cells were exposed to tBid or Bim, death effectors activated by therapeutic stress. Multidrug-resistant tumor cells obtained from children at relapse had markedly attenuated Bak and Bax oligomerization and cytochrome c release (surrogates for apoptotic commitment) in comparison with patient-matched tumor cells obtained at diagnosis. Electron microscopy identified reduced ER-mitochondria-associated membranes (MAMs; ER-mitochondria contacts, ERMCs) in therapy-resistant cells, and genetically or biochemically reducing MAMs in therapy-sensitive tumors phenocopied resistance. MAMs serve as platforms to transfer Ca2+ and bioactive lipids to mitochondria. Reduced Ca2+ transfer was found in some but not all resistant cells, and inhibiting transfer did not attenuate apoptotic signaling. In contrast, reduced ceramide synthesis and transfer was common to resistant cells and its inhibition induced stress resistance. We identify ER-mitochondria-associated membranes as physiologic regulators of apoptosis via ceramide transfer and uncover a previously unrecognized mechanism for cancer multidrug resistance.
Links
GJ20-00987Y, research and development projectName: Mitochondriální dynamika a autofagie: Chybějící článek mezi dediferenciací a vznikem rezistence u solidních nádorů dětského věku
Investor: Czech Science Foundation
PrintDisplayed: 1/9/2024 04:21